We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Mycelx Technologies Corporation | LSE:MYX | London | Ordinary Share | COM SHS USD0.025 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
4.00 | 7.41% | 58.00 | 56.00 | 60.00 | 59.50 | 54.00 | 55.00 | 202,342 | 14:27:38 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Water Supply | 10.91M | -3.71M | -0.1612 | -3.60 | 12.41M |
TIDMMYX
MyCelx Technologies Corporation
24 January 2023
24 January 2023
MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)
Rental Contract Secured for PFAS Remediation System at Landfill
MYCELX Technologies Corporation ("MYCELX" or the "Company"), the clean water and clean air technology company, is pleased to announce that it has secured a paid 6-month trial for treatment of PFAS in the United States. PFAS, which stands for per-fluoroalkyl and poly-fluoroalkyl compounds, are a collection of long-lasting manmade toxic chemicals which present a global threat to human health and the environment.
MYCELX has secured a contract for its fully containerized, mobile PFAS remediation system which includes MYCELX infused cartridge filtration and Performer(TM) media. The system will be utilized for treating PFAS contaminated leachate from a solid waste landfill. The rental is expected to successfully demonstrate the ability of the proprietary MYCELX technology to completely remove all identified PFAS chemicals to non-detectable concentrations in a single pass.
The revenue from this trial is not anticipated to alter management's revenue expectations for the year.
Connie Mixon, CEO, commented:
"We are pleased to announce this promising paid trial. The award is further proof of the strong momentum we are generating as a business in the PFAS solutions market, building on the Company's success with its previous trial in America and installations in Australia with an important distributor. In addition, in scenarios of solid waste landfill, we continue to see a growing demand for technologies that are able to treat the co-contaminants that are present with PFAS.
As a Group, we are firmly focused on achieving greater market share in three core areas; the Middle East, PFAS and REGEN. All of which we believe will be key growth drivers for MYCELX in 2023. We look forward to updating all our stakeholders on further corporate developments over the coming months."
For further information, please contact:
MYCELX Technologies Corporation Connie Mixon, CEO Tel: +1 888 306 6843 Kim Slayton, CFO Canaccord Genuity Limited (Nomad and Sole Broker) Henry Fitzgerald-O'Connor Tel: +44 20 7523 8000 Gordon Hamilton Celicourt Communications (Financial PR) Mark Antelme Tel: +44 20 8434 2754 Jimmy Lea
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRANKNBKCBKDQDB
(END) Dow Jones Newswires
January 24, 2023 02:00 ET (07:00 GMT)
1 Year Mycelx Technologies Chart |
1 Month Mycelx Technologies Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions